Preview

Rational Pharmacotherapy in Cardiology

Advanced search

THE INFLUENCE OF INSULIN RESISTANCE ON THE FORMATION AND PROGRESSION OF METABOLIC SYNDROME COMPONENTS (THE RESULTS OF A FIVE-YEAR STUDY)

https://doi.org/10.20996/1819-6446-2015-11-2-132-138

Full Text:

Abstract

The combination of risk factors that make up a metabolic syndrome increases the risk of cardiovascular disease and type 2 diabetes. In the presence of insulin resistance the effects of risk factors combine, thereby increasing the probability of the development of cardiovascular disease and its complications.

Aim. To study the effect of insulin resistance on the formation and progression of metabolic syndrome components on the basis of a 5-year follow-up.

Material and methods. An outpatient examination of clinically healthy patients aged 20-65 years (n=711; 327 men and 384 women) was conducted. The average body mass index did not exceed 34.5 kg/m2. Biochemical blood analysis was performed to assess the state of lipid and carbohydrate metabolism. Insulin resistance was diagnosed using HOMAIR>2.6.

Results. It has been detected that patients with insulin resistance have significantly higher incidence of the combination of three or more components of the metabolic syndrome (p<0.01). The incidence of multicomponent syndrome among the examined patients with insulin resistance was 69.7%, which is 1.8 times higher than in patients with initially preserved tissue sensitivity to insulin.

Conclusion. The follow-up study of patients with insulin resistance shows that in the absence of correction of metabolic disorders, the development of multicomponent disorders that make up a metabolic syndrome occurs.

About the Authors

G. E. Roytberg
Pirogov Russian National Research Medical University
Russian Federation
Ostrovitianova ul. 1, Moscow, 117997 Russia


J. V. Dorosh
Pirogov Russian National Research Medical University
Russian Federation
Ostrovitianova ul. 1, Moscow, 117997 Russia


O. O. Sharkhun
Pirogov Russian National Research Medical University
Russian Federation
Ostrovitianova ul. 1, Moscow, 117997 Russia


References

1. DECODE Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999;354:617-21.

2. Roytberg GE. Metabolic syndrome. Moscow: MEDpress-inform; 2007. Russian (Ройтберг Г.Е. Мета-болический синдром. М.: МЕДпресс-информ; 2007).

3. Tkachuk VA, Vorotnikov AV. Molecular mechanisms of insulin resistance. Sakharnyy Diabet 2014; (2): 29-40. Russian (Ткачук В.А., Воротников А.В. Молекулярные механизмы развития резистентно-сти к инсулину. Сахарный Диабет 2014; (2): 29-40).

4. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link. Atherosclerosis 2000;148(2):209-14.

5. Roytberg GE, Ushakova TI, Dorosh JV. Role of insulin resistance in the diagnosis of metabolic syndrome. Kardiologiia 2004; (3): 94-101. Russian (Ройтберг Г.Е., Ушакова Т.И., Дорош Ж.В. Роль инсули-норезистентности в диагностике метаболического синдрома. Кардиология 2004; (3): 94-101).

6. Roytberg GE, Ushakova TI Sharhun OO, Dorosh JV. The integrated approach to the diagnosis of metabolic syndrome in clinical practice. Kardiologiia 2012; 10: 45-50. Russian (Ройтберг Г.Е., Ушакова Т.И., Шархун О.О., Дорош Ж.В. Интегральный подход к диагностике метаболического синдрома в кли-нической практике. Кардиология 2012; 10: 45-50).

7. Roytberg GE, Dorosh JV, Sharhun OO, et al. Features of the new metabolic index in the evaluation of insulin resistance in clinical practice. Ration Pharmacother Cardiol 2014; 10 (3): 264-74. Russian (Ройт-берг Г.Е., Дорош Ж.В., Шархун О.О., и др. Возможности применения нового метаболического ин-декса при оценке инсулинорезистентности в клинической практике. Рациональная Фармакоте-рапия в Кардиологии 2014; 10(3): 264-74).

8. Shangraw R.E., Jahoor F., Miyoshi H., et al. Differentiation between septic and postburn insulin resistance. Metabolism 1989;38(10):983-9.

9. Snel M., Jonker J.T., Schoones J., et al. Ectopic Fat and Insulin Resistance: Pathophysiology and Effect of Diet and Lifestyle Interventions. International Journal of Endocrinology 2012;12:1-18.

10. Schwartz M.W., Seeley R.J., Tschöp M.H., et al. Cooperation between brain and islet in glucose homeostasis and diabetes. Nature 2013;503(7474):59–66.

11. Diagnosis and treatment of metabolic syndrome. Russian guidelines. 2nd revision. Prakticheskaya Meditsina 2010; 44: 81-101. Russian (Диагностика и лечение метаболического синдрома. Россий-ские рекомендации. 2-й пересмотр. Практическая Медицина 2010; 44: 81-101).

12. Suntsov YI, Dedov II. The State Register of diabetes - the basic information system to calculate the economic costs of the state for diabetes and forecasting. Sakharnyy Diabet 2005; 2: 2-5. Russian (Су-нцов Ю.И., Дедов И.И. Государственный регистр сахарного диабета – основная информационная система для расчета экономических затрат государства на сахарный диабет и их прогнозиро-вание. Сахарный Диабет 2005; 2: 2-5).

13. Diagnostics and correction of lipid disorders for the prevention and treatment of atherosclerosis. Russian recommendations. 5th revision. Available at http://webmed.irkutsk.ru/doc/pdf/noa2012full.pdf. Accessed by 02/04/2015. Russian (Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации. 5-й пересмотр. До-ступно на http://webmed.irkutsk.ru/doc/pdf/noa2012full.pdf. Проверено 02.04.2015).

14. Diagnosis and treatment of hypertension. Clinical guidelines (2013). Available at: http://webmed.irkutsk.ru/doc/pdf/fedhypert.pdf. Accessed by 02/04/2015. Russian (Диагностика и лечение арте-риальной гипертонии. Клинические рекомендации (2013). Доступно на: http://webmed.irkutsk.ru/doc/pdf/fedhypert.pdf. Проверено 02.04.2015).

15. Hong Y., Jin X., Mo J. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all–cause mortality – results of prospective analysis for the Atherosclerosis Risk in Communities study. J Intern Med 2007; 262(1): 113-23.

16. Suntsov YI, Bolotskaya LL, Maslova OV, Kazakov IV. Epidemiology and prognosis of diabetes prevalence in the Russian Federation. Sakharnyy Diabet 2011; 1; 15-9. Russian (Сунцов Ю.И., Болотская Л.Л., Маслова О.В., Казаков И.В. Эпидемиология сахарного диабета и прогноз его распро-страненности в Российской Федерации. Сахарный диабет 2011; 1; 15-9).

17. Liu M., Pan C., Jin M. A. Chinese diabetes risk score for screening of undiagnosed diabetes and abnormal glucose tolerance. Diabetes Technol Ther 2011;13(5):501-7.

18. Noble D.L., Mathur R., Dent T., Meads C., Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. BMJ 2011;343:d7163.

19. Misnikova IV, Dreval AV, Kovaleva JA, et al. Optimization of screening for early detection of disorders of carbohydrate metabolism. Sakharnyy Diabet 2014; 1: 8-14. Russian (Мисникова И.В., Древаль А.В., Ковалева Ю.А., и др. Оптимизация скрининга для раннего выявления нарушений угле-водного обмена. Сахарный Диабет 2014; 1: 8-14).


For citation:


Roytberg G.E., Dorosh J.V., Sharkhun O.O. THE INFLUENCE OF INSULIN RESISTANCE ON THE FORMATION AND PROGRESSION OF METABOLIC SYNDROME COMPONENTS (THE RESULTS OF A FIVE-YEAR STUDY). Rational Pharmacotherapy in Cardiology. 2015;11(2):132-138. (In Russ.) https://doi.org/10.20996/1819-6446-2015-11-2-132-138

Views: 523


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)